Persistent Methicilin-Resistant Staphylococcus aureus Bacteremia: Resetting the Clock for Optimal Management

Area of Science:

• Infectious Diseases
• Clinical Microbiology
• Medical Therapeutics

Background:

• Persistent bacteremia from methicillin-resistant Staphylococcus aureus (MRSA) despite appropriate therapy is a frequent and concerning clinical scenario.
• Current definitions and management strategies for prolonged MRSA bacteremia lack standardization.
• Identifying metastatic infection sites is crucial for effective treatment.

Purpose of the Study:

• To establish a definition for persistent MRSA bacteremia.
• To propose a management algorithm for patients with persistent MRSA bacteremia.
• To suggest pragmatic clinical trial designs for evaluating treatment strategies.

Main Methods:

• Defining bacteremia lasting longer than one calendar day as a "worry point" requiring intensive diagnostic evaluation.
• Outlining criteria for antibiotic failure in MRSA bacteremia.
• Proposing clinical trial frameworks for testing novel treatment approaches.

Main Results:

• A "worry point" is identified at >1 calendar day of bacteremia, necessitating a search for metastatic infection.
• Specific durations of MRSA bacteremia are proposed as indicators of likely antibiotic failure.
• Pragmatic clinical trial designs are suggested to address knowledge gaps.

Conclusions:

• Standardized definitions and management algorithms are needed for persistent MRSA bacteremia.
• Early identification of metastatic sites and timely intervention are critical.
• Further clinical trials are essential to optimize treatment for persistent MRSA bacteremia.